Drug prescription including interactions with anticancer treatments in the elderly: A global approach

被引：6

作者：

Rougé Bugat M.-E. ^{[1
,2
,3
,5
]}

Bourgouin M. ^{[3
]}

Gérard S. ^{[4
]}

Lozano S. ^{[4
]}

Brechemier D. ^{[4
]}

Cestac P. ^{[2
]}

Cool C. ^{[2
]}

Balardy L. ^{[3
,4
]}

机构：

[1] University Department of General Practice, Toulouse-Rangueil Faculty of Medicine, Toulouse

[2] Faculty of Medicine, Inserm U1027, Toulouse

[3] University Department of Oncology, Toulouse University Cancer Institute IUCT-Oncopole

[4] Gérontopole, Centre Hospitalo-Universitaire de Toulouse, Toulouse

[5] DESC Oncology, 59 rue de la Providence, Toulouse

来源：

The journal of nutrition, health & aging | 2017年 / 21卷 / 8期

关键词：

adverse drug events; cancer; drug interaction; elderly patients; Polymedication; potentially inappropriate prescription;

D O I：

10.1007/s12603-017-0946-8

中图分类号：

学科分类号：

摘要：

Background: Consequences of inappropriate prescriptions and polymedication in patients suffering from cancer are beginning to be well documented. However, the methods used to evaluate these consequences are often discussed. Few studies evaluate the risk of interaction with anticancer drugs in elderly patients suffering from cancer. Objectives: To describe the prevalence (i) of polypharmacy, (ii) of potentially inappropriate drug prescriptions and (iii) of drug interactions involving anticancer treatments, using a multiple reference tools. Design: A retrospective, cross-sectional, multicenter study performed from January to December 2012. Participants: Patients aged 65 years or older suffering from cancer presented at the oncogeriatric multidisciplinary meeting. Measurements: Polymedication (>6 drugs), potentially inappropriate prescriptions and drug interactions involving anticancer treatment were analyzed in combination with explicit and implicit criteria within a global approach. Results: Among the 106 patients included in this study, polypharmacy was present in 60.4% of cases, potentially inappropriate drug prescription in 63.1% and drug interactions in 16% of case, of which 47% involved anti-cancer treatments. Twenty-seven major drug interactions were identified and eight interactions involved chemotherapy. Conclusion: Polymedication, inappropriate prescribing and drug interactions involving anti-cancer drugs are common and largely underestimated in elderly cancer patients. © 2017, Serdi and Springer-Verlag France SAS.

引用

页码：849 / 854

页数：5

共 54 条

[1]

Extermann M., Boler I., Reich R.R., Lyman G.H., Brown R.H., DeFelice J., Et al., Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score, Cancer., 118, 13, pp. 3377-3386, (2012)

[2]

Caillet P., Laurent M., Bastuji-Garin S., Liuu E., Culine S., Lagrange J.L., Et al., Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment, Clin interventions aging., 9, pp. 1645-1660, (2014)

[3]

Gerard S., Brechemier D., Lefort A., Lozano S.A.V., Kan G., Filleron T., Et al., Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects- A Systematic Review, J Nutr Health Aging., 20, 8, pp. 878-888, (2016)

[4]

Hurria A., Togawa K., Mohile S.G., Owusu C., Klepin H.D., Gross C.P., Et al., Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study, J Clin Oncol., 29, 25, pp. 3457-3465, (2011)

[5]

Alkan A., Yasar A., Karci E., Koksoy E.B., Urun M., Senler F.C., Et al., Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients, Supportive Care Cancer., 25, 1, pp. 229-236, (2017)

[6]

Nightingale G., Hajjar E., Swartz K., Andrel-Sendecki J., Chapman A., Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer, J J Clin Oncol., 33, 13, pp. 1453-1459, (2015)

[7]

Saarelainen L.K., Turner J.P., Shakib S., Singhal N., Hogan-Doran J., Prowse R., Et al., Potentially inappropriate medication use in older people with cancer: prevalence and correlates, J Geriatric Oncol., 5, 4, pp. 439-446, (2014)

[8]

Popa M.A., Wallace K.J., Brunello A., Extermann M., Balducci L., Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy, J Geriatric Oncol., 5, 3, pp. 307-314, (2014)

[9]

Tam-McDevitt J., Polypharmacy, aging, and cancer, Oncology., 22, 9, pp. 1052-1055, (2008)

[10]

Turner J.P., Jamsen K.M., Shakib S., Singhal N., Prowse R., Bell J.S., Polypharmacy cutpoints in older people with cancer: how many medications are too many?, Supportive Care Cancer, 24, 4, pp. 1831-1840, (2016)

← 1 2 3 4 5 6 →